Ignite Creation Date:
2025-12-24 @ 10:16 PM
Ignite Modification Date:
2025-12-25 @ 7:50 PM
Study NCT ID:
NCT00746135
Status:
COMPLETED
Last Update Posted:
2019-02-04
First Post:
2008-08-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study
Sponsor:
Abbott Medical Devices
Organization:
Study Overview
Official Title:
TRI-V Resynchronization in Paced Heart Failure Patients With ICD Indication.
Status:
COMPLETED
Status Verified Date:
2019-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TRI-V
Brief Summary:
It's the aim of this study to investigate the impact of Right Ventricular (RV) lead position (RV-apex, His bundle area, RV-apex+His bundle area) in combination with individually optimized Left Ventricular (LV) lead placement and CRT timing on the outcome of cardiac resynchronization therapy (CRT).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: